IREN Budgets $25 Billion To $30 Billion For Its AI Build-Out — More Than Its Entire $13.9 Billion Market Value
IREN stock has plunged 54% from highs earlier this year.
Latest
Arista CEO Jayshree Ullal's Trusts Sold $21.1 Million Of Stock Under A Plan Set In November 2025
A Form 4 shows three trust accounts sold 96,992 shares on Wednesday, the fourth sale in her five latest filings.
Bambusa Files For Nasdaq IPO With $41.1 Million Loss, No Revenue And A Going-Concern Warning
The Boston antibody developer's S-1 leaves price and share count blank and says $71.5 million in cash may not last a year.
Standard BioTools Holders Would Own About 16% Of Treeline Combination, Amended S-4 Shows
The second amended filing sets an exchange ratio range, a 12-seat board and a $2.5 billion Treeline value against $460 million for Standard BioTools.
EU Names Eldorado Gold's Skouries Mine A Strategic Project, Backing A $2 Billion-Plus Greek Copper Build
The European Commission picked the Greek copper-gold mine under its Critical Raw Materials Act, the company said in a statement.
AutoZone Director Claire McDonough Will Leave The Board In 2026 Over A Calendar Clash, Not A Dispute
McDonough told AutoZone's board she will not stand for reelection after taking a new executive job whose calendar conflicts with board meetings.
Integra Prices $450 Million Of 9.500% Notes, Expects Rate Increase Near High End Of 100-200 Basis Point Range
The refinancing is expected to raise Integra's effective interest rate near the top of the range management flagged earlier.
Sidus Space Audit Chair And Another Director Resign Same Day, And The Company Disputes Both Letters
An 8-K shows Tiffany Norwood and Kelle Wendling left the board Tuesday; Sidus Space says it disagrees with their letters.
Live Nation Prices $730 Million And €600 Million Of Notes To Pay Off 6.500% Debt
Live Nation says swaps on its dollar notes put the blended rate at about 5.89%, against 6.500% on the 2027 notes it will redeem.
Crescent Energy Prices 80 Million Shares At $12.50 To Help Fund Devon Eagle Ford Purchase
A KKR-affiliated holder agreed to buy 40 million shares, and underwriters took up their full 12 million-share option on Friday.
Fairmount-Linked Holders Of 9.99% Of Spyre Therapeutics Agree To 60-Day Lock-Up After Offering
Amendment No. 8 to a Schedule 13D reports the lock-up only; the holders did not buy shares and their position is unchanged since June.
Dolan Reports 100 MSGS Spinco Shares, All Held Indirectly, As Spinoff Registration Takes Effect
James Dolan's Form 3 lists 100 shares held through Madison Square Garden Sports and its subsidiaries, and he disclaims ownership.
Markets
FDA Tells Amazon Nine Herpes Products It Shipped Are Unapproved Drugs, Sets 15-Business-Day Deadline
The FDA bought the over-the-counter products on amazon.com in July and says Amazon's fulfillment service delivered them to consumers for third parties.
Markets
Repligen Closes BioLife Deal: 0.1442 Shares Plus $11.25 Cash Per Share, And Every Director Is Gone
BioLife is now a Repligen subsidiary after a Monday stockholder vote, and plans to deregister from the SEC.
Markets
Option Care Health Agrees To $32.05-A-Share Cash Buyout By CD&R And McKesson
The deal values the home-infusion company at about $5.8 billion, with a $145,963,976 fee if Option Care Health walks away in specified cases.
Markets
Trump Order Gives Treasury 5 Days To Decide On Deferring Diesel Excise Tax Through December
The executive order sets no relief itself; Treasury must first decide whether it has authority, and the White House cites restricted global diesel supply.
Markets
116 Companies Filed 8-Ks In The 90 Minutes After Friday's Close — Here Are The 14 That Matter
We analyzed a massive wave of filings between 4:00 and 5:29 p.m. ET on Friday, including 40 executive changes, 8 Nasdaq notices, 1 auditor dismissed, and 1 restatement.
Markets
America's Job Market Has Barely Moved In Seven Months — And September's Numbers Show Why That's A Problem
The U.S. added just 29,000 nonfarm jobs in September, and the unemployment rate has been locked in a 4.1–4.3 percent band since March.
Markets
Vylor Enters The S&P 500 On Its First Day Of Trading, Inheriting Corteva's Slot After Thursday's Spin-Off
The advanced seed and genetics company targets $11.2 billion to $11.9 billion in net sales by 2029 and carries a $19 billion technology pipeline.